JP Morgan Chase’s Kindred Healthcare KND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-2,618,427
| Closed | -$23.6M | – | 5988 |
|
|
2018
Q2 | $23.6M | Sell |
2,618,427
-2,304,113
| -47% | -$20.6M | ﹤0.01% | 1457 |
|
|
2018
Q1 | $45M | Sell |
4,922,540
-1,154,891
| -19% | -$10.7M | 0.01% | 997 |
|
|
2017
Q4 | $59M | Buy |
6,077,431
+2,504,747
| +70% | +$18.6M | 0.01% | 902 |
|
|
2017
Q3 | $24.8M | Buy |
3,572,684
+1,468,066
| +70% | +$12.5M | 0.01% | 1365 |
|
|
2017
Q2 | $24.5M | Buy |
2,104,618
+1,260,753
| +149% | +$12.4M | 0.01% | 1323 |
|
|
2017
Q1 | $7.05M | Buy |
843,865
+229,261
| +37% | +$1.79M | ﹤0.01% | 2183 |
|
|
2016
Q4 | $4.83M | Sell |
614,604
-56,362
| -8% | -$463K | ﹤0.01% | 2491 |
|
|
2016
Q3 | $6.86M | Buy |
670,966
+24,612
| +4% | +$273K | ﹤0.01% | 2033 |
|
|
2016
Q2 | $7.3M | Sell |
646,354
-58,277
| -8% | -$730K | ﹤0.01% | 2044 |
|
|
2016
Q1 | $8.7M | Buy |
704,631
+237,805
| +51% | +$2.47M | ﹤0.01% | 1851 |
|
|
2015
Q4 | $5.56M | Sell |
466,826
-33,161
| -7% | -$429K | ﹤0.01% | 2158 |
|
|
2015
Q3 | $7.88M | Buy |
499,987
+19,312
| +4% | +$391K | ﹤0.01% | 1934 |
|
|
2015
Q2 | $9.75M | Buy |
480,675
+142,491
| +42% | +$3.26M | ﹤0.01% | 1942 |
|
|
2015
Q1 | $8.05M | Sell |
338,184
-379,442
| -53% | -$7.7M | ﹤0.01% | 2042 |
|
|
2014
Q4 | $13M | Buy |
717,626
+434,194
| +153% | +$8.6M | ﹤0.01% | 1766 |
|
|
2014
Q3 | $5.5M | Sell |
283,432
-139,076
| -33% | -$3.03M | ﹤0.01% | 2308 |
|
|
2014
Q2 | $9.76M | Buy |
422,508
+249,246
| +144% | +$6.09M | ﹤0.01% | 1760 |
|
|
2014
Q1 | $4.06M | Sell |
173,262
-60,176
| -26% | -$1.24M | ﹤0.01% | 2207 |
|
|
2013
Q4 | $4.61M | Sell |
233,438
-99,497
| -30% | -$1.6M | ﹤0.01% | 2226 |
|
|
2013
Q3 | $4.47M | Sell |
332,935
-4,170
| -1% | -$60K | ﹤0.01% | 2254 |
|
|
2013
Q2 | $4.43M | Buy |
+337,105
| New | +$4.03M | ﹤0.01% | 2217 |
|
JP Morgan Chase's KND Position: Q3 2018 in Review
JP Morgan Chase sold out of Kindred Healthcare (KND) in Q3 2018, closing a stake of 2,618,427 shares — an estimated $23.6M sold.
JP Morgan Chase first reported a position in KND in Q2 2013 and held it in 21 quarters. The position peaked at $59M in Q4 2017. 0 funds tracked by Wall St. Rank hold KND as of Q3 2018.
- JP Morgan Chase reported no remaining Kindred Healthcare position as of Q3 2018 after selling out during the quarter.
- JP Morgan Chase sold 2,618,427 Kindred Healthcare shares in Q3 2018, an estimated $23.6M.
- JP Morgan Chase first reported a position in Kindred Healthcare in Q2 2013 and held it in 21 quarters.
- JP Morgan Chase's Kindred Healthcare position peaked at $59M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Kindred Healthcare as of Q3 2018.
Based on JP Morgan Chase's 13F filing for Q3 2018, filed 7 Nov 2018.